Cancer risk hits calcitonin companies as Canada, US assess evidence
This article was originally published in Scrip
Executive Summary
Health Canada is assessing the safety of long-term use of drugs containing calcitonin on the back of new recommendations from the European Medicines Agency (EMA) to restrict calcitonin use "due to evidence suggesting an increased risk of cancer".